GLP Watchdog

altRX vs Wisp

altRX has an open FDA warning letter dated June 8, 2026. Wisp has none. No price lines up like for like: altRX and Wisp publish prices for different products.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

altRX / Wisp

Featured pick (affiliate partner)

altRX logo

altRX

8.8/10

Wisp logo

Wisp

7.1/10

FDA warning letters
None on record
Pharmacy
  • RedRock Pharmacy503A
  • Health Warehousetype not stated
  • Precision Medicinetype not stated
  • and 1 more
None named in our record
Lowest standing price
$89/moCompounded semaglutide injection
$225/moCompounded oral semaglutide
States
All 50 states
39 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked September 2026
Visit altRX
Visit Wisp

altRX is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Wisp pays us nothing. The scores are computed the same way for both and are shown as computed (altRX 8.8, Wisp 7.1). How we are paid

What the record shows

  1. 01

    altRX has an open FDA warning letter dated June 8, 2026. Wisp has none.

  2. 02

    altRX names four pharmacies. Wisp names no compounding pharmacy in our record.

  3. 03

    No price lines up like for like: altRX and Wisp publish prices for different products.

  4. 04

    Only altRX lists a price for compounded semaglutide injection, compounded tirzepatide injection and brand-name semaglutide pen. Only Wisp lists a price for compounded oral semaglutide.

  5. 05

    AltRX covers 11 states Wisp does not.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

altRX

Wisp

Compounded semaglutide injection

$89/mo

$1,068 a year

Not sold or not priced
Compounded tirzepatide injection

$149/mo

$1,788 a year

Not sold or not priced
Brand-name semaglutide pen

$1,149/mo

$13,788 a year

Not sold or not priced
Brand-name tirzepatide pen

$1,249/mo

$14,988 a year

Not sold or not priced
Compounded oral semaglutide
Not sold or not priced

$225/mo

$2,700 a year

Price includes
Medication, clinician visits, shipping
Medication, shipping
Cancel any time
Yes, stated
Yes, stated
Minimum term
None on the monthly plan; multi-month plans are prepaid and non-refundable
Not stated
Refunds
All payments are final and non-refundable, except a partial refund if you are medically disqualified
All sales are final

Read off each seller’s own pages. altRX: September 28, 2026. Wisp: September 28, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for altRX

8.8/10
Featured pick (affiliate partner)
  • Sells compounded semaglutide injection and compounded tirzepatide injection, which Wisp does not price
  • Names its compounding pharmacy
  • Lists 50 states against 39
  • Open FDA warning letter, June 8, 2026
Visit altRX

The case for Wisp

7.1/10
  • No FDA warning letter on record
  • Sells compounded oral semaglutide, which altRX does not price
  • Names no compounding pharmacy
Visit Wisp

Scores

altRX 8.8 · Wisp 7.1 out of 10. Six weighted parts.

Value25%

10.0A
vs
B
4.1

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

6.0A
vs
B
7.5

Accessibility10%

10.0A
vs
B
8.2

Support10%

7.0A
vs
B
4.5

The score is the same formula for every seller. Payment does not enter it. Method

altRX vs Wisp: questions

altRX has an open FDA warning letter dated June 8, 2026. Wisp has none. Letters are matched to a seller by company, domain and address, never by a similar name.
altRX names four pharmacies. Wisp names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
No price lines up like for like: altRX and Wisp publish prices for different products. We only set two prices against each other when they are for the same product and both are standing month-to-month or 4-week rates.
altRX states you can cancel at any time; refunds: all payments are final and non-refundable, except a partial refund if you are medically disqualified. Wisp states you can cancel at any time; refunds: all sales are final.
altRX is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Wisp pays us nothing. The scores are computed the same way for both and are shown as computed (altRX 8.8, Wisp 7.1).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks